The study involved four major activities in estimating the current market size for Global Sleep Apnea Devices Industry. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and sub-segments

Recent Developments:

# In 2019, ResMed (US) launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the US with a newly designed nasal cradle cushion that sits just under the wearer’s nose.

# In 2016, Koninklijke Philips (Netherlands) launched its Dream Family solution which comprises of a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app.

Key Questions Addressed by the Report:

# Which type segment will dominate the market in the future?
# Emerging countries have immense opportunities for the growth and adoption of sleep apnea devices, therefore will this scenario continue in the next five years?
# Where will all the advancements in technology offered by various companies take the industry in the mid to long term?
# What are the upcoming alternative therapies and devices related to the same in the sleep apnea devices market?

Find More Details | Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Objectives behind This Study:

# To define, describe, and measure the global sleep apnea devices market by type, end user, and region

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and the Rest of the world (RoW)

# To strategically analyze the market structure and profile key players and their core competencies3 in the global sleep apnea devices market

# To track and analyze competitive developments such as service launches, expansions, acquisitions, partnerships & collaborations; in the sleep apnea devices market.

Factors Influencing Global Growth:-

Growth in the sleep apnea devices market can be attributed to factors such as a large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, influx of venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets.

Also, there are growth opportunities for the market due to the increasing demand for home healthcare and increasing focus on telemedicine and mHealth (mobile Health).

Restraints:
# High Cost of CPAP Machines
# Complex Referral Pathways and Long Waiting Periods

Opportunities:
# Growing Demand for Home Healthcare
# Increasing Focus on Telemedicine and Mhealth (Mobile Health)

Challenges:
# Lack of Patient Compliance

Monetary Growth Expectations, Globally:

The global sleep apnea devices market is expected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%.

Feel FREE to Connect to Our Research Experts@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=719

Geographical Growth Scenario:

On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period.

North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.

Leading Market Players:

# ResMed (US)
# Koninklijke Philips (Netherlands)
# Fisher & Paykel Healthcare (New Zealand)
# SomnoMed (US)
# Oventus Medical (Australia)
# Compumedics (Australia) and many more…

Analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as partnerships & agreements, expansions, service launches, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the sleep apnea devices market.

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]